SK283503B6 - Farmaceutický prostriedok na liečbu akútnej bolesti - Google Patents

Farmaceutický prostriedok na liečbu akútnej bolesti Download PDF

Info

Publication number
SK283503B6
SK283503B6 SK401-2001A SK4012001A SK283503B6 SK 283503 B6 SK283503 B6 SK 283503B6 SK 4012001 A SK4012001 A SK 4012001A SK 283503 B6 SK283503 B6 SK 283503B6
Authority
SK
Slovakia
Prior art keywords
pharmaceutical composition
fentanyl
composition according
bio
carrier particles
Prior art date
Application number
SK401-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK4012001A3 (en
Inventor
Anders Pettersson
Christer Nystrm
Hans Lennerns
Bo Lennern�S
Thomas Hedner
Original Assignee
Diabact Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20412701&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK283503(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Diabact Ab filed Critical Diabact Ab
Publication of SK4012001A3 publication Critical patent/SK4012001A3/sk
Publication of SK283503B6 publication Critical patent/SK283503B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK401-2001A 1998-09-24 1999-09-24 Farmaceutický prostriedok na liečbu akútnej bolesti SK283503B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9803239A SE9803239D0 (sv) 1998-09-24 1998-09-24 Composition for the treatment of acute pain
PCT/SE1999/001688 WO2000016751A1 (fr) 1998-09-24 1999-09-24 Composition de fentanyl pour le traitement des douleurs aigues

Publications (2)

Publication Number Publication Date
SK4012001A3 SK4012001A3 (en) 2001-10-08
SK283503B6 true SK283503B6 (sk) 2003-08-05

Family

ID=20412701

Family Applications (1)

Application Number Title Priority Date Filing Date
SK401-2001A SK283503B6 (sk) 1998-09-24 1999-09-24 Farmaceutický prostriedok na liečbu akútnej bolesti

Country Status (26)

Country Link
US (1) US6759059B1 (fr)
EP (1) EP1115384B1 (fr)
JP (2) JP2002526440A (fr)
KR (1) KR100760531B1 (fr)
CN (1) CN1170524C (fr)
AT (1) ATE247950T1 (fr)
AU (1) AU764473B2 (fr)
BG (1) BG65363B1 (fr)
BR (1) BR9913948B1 (fr)
CA (1) CA2345064C (fr)
CZ (1) CZ301562B6 (fr)
DE (1) DE69910803T2 (fr)
DK (1) DK1115384T3 (fr)
EE (1) EE200100176A (fr)
ES (1) ES2207295T3 (fr)
HU (2) HU230688B1 (fr)
IL (2) IL142126A0 (fr)
NO (1) NO332228B1 (fr)
NZ (1) NZ510646A (fr)
PL (1) PL197078B1 (fr)
PT (1) PT1115384E (fr)
RU (1) RU2232580C2 (fr)
SE (1) SE9803239D0 (fr)
SK (1) SK283503B6 (fr)
TR (1) TR200100812T2 (fr)
WO (1) WO2000016751A1 (fr)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6974590B2 (en) * 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US20030118645A1 (en) * 1998-04-29 2003-06-26 Pather S. Indiran Pharmaceutical compositions for rectal and vaginal administration
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
SE9803240D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
ATE526950T1 (de) 1999-10-29 2011-10-15 Euro Celtique Sa Hydrocodon-formulierungen mit gesteuerter freisetzung
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
IT1318618B1 (it) * 2000-07-10 2003-08-27 A C R Applied Coating Res S A Microsfere bioadesive a rilascio rapido per la somministrazionesublinguale di principi attivi.
DK1307194T4 (da) 2000-07-31 2011-07-18 Nycomed Danmark Aps Fentanylpræparat til nasal administration
EP2263658A1 (fr) 2000-10-30 2010-12-22 Euro-Celtique S.A. Formulations d'hydrocodone à liberation lente
AU2002303148A1 (en) * 2001-06-29 2003-03-03 Leon J. Lewandowski Individualized addiction cessation therapy
FR2827517B1 (fr) 2001-07-23 2003-10-24 Bioalliance Pharma Systemes therapeutiques bioadhesifs a liberation prolongee
DE60219124T2 (de) * 2001-11-16 2008-01-31 Randox Laboratories Ltd., Crumlin Verfahren und Kit zum Nachweis, oder zum Quantifizieren von, Metaboliten von Fentanyl und Metaboliten von Fentanyl Analoga
GB0217056D0 (en) * 2002-07-23 2002-08-28 Ass Octel Use
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
EP1587514B3 (fr) * 2003-01-31 2011-06-22 Orexo AB Composition pharmaceutique a effet rapide
WO2004080382A2 (fr) * 2003-03-11 2004-09-23 Arakis Ltd. Nouvelles compositions
JP5137286B2 (ja) 2003-06-10 2013-02-06 帝國製薬株式会社 フェンタニル含有口腔粘膜貼付剤
GB0315632D0 (en) 2003-07-04 2003-08-13 West Pharm Serv Drug Res Ltd Pharmaceutical formulations
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
WO2005065319A2 (fr) 2003-12-31 2005-07-21 Cima Labs Inc. Forme galenique de fentanyl generalement lineaire effervescente et orale et ses procedes d'administration
AU2004311879B2 (en) 2003-12-31 2010-08-05 Cima Labs Inc. Effervescent oral opiate dosage form
US7858121B2 (en) 2003-12-31 2010-12-28 Cima Labs, Inc. Effervescent oral fentanyl dosage form and methods of administering fentanyl
KR20070030178A (ko) * 2004-02-17 2007-03-15 트랜스오랄 파마슈티칼스, 인코포레이티드 구강 점막을 가로지르는 수면제 전달용 조성물 및 이의사용 방법
GB0423800D0 (en) * 2004-10-27 2004-12-01 Orexo Ab New pharmaceutical formulations
FR2883179B1 (fr) * 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
EP1863456A1 (fr) * 2005-03-28 2007-12-12 Orexo AB Nouvelles compositions pharmaceutiques utiles dans le traitement de la douleur
US20060276501A1 (en) * 2005-05-25 2006-12-07 Transoral Pharmaceuticals, Inc. Solid compositions for treating middle-of-the-night insomnia
US20070225322A1 (en) * 2005-05-25 2007-09-27 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the night insomnia
US20070287740A1 (en) * 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
CN101330903B (zh) * 2005-12-13 2015-07-08 生物递送科学国际公司 防滥用的经黏膜给药装置
CN101495080B (zh) * 2006-01-06 2013-10-23 阿塞尔Rx制药有限公司 药物存储及发放装置以及包括该装置的系统
US8357114B2 (en) 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US9289583B2 (en) 2006-01-06 2016-03-22 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8202535B2 (en) 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US9066847B2 (en) * 2007-01-05 2015-06-30 Aceirx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US8252329B2 (en) * 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8753308B2 (en) 2006-01-06 2014-06-17 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8865743B2 (en) 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8252328B2 (en) * 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
DK1976521T3 (en) * 2006-01-25 2015-04-27 Insys Therapeutics Inc Sublingual fentanyl spray
EP1837020A1 (fr) 2006-03-24 2007-09-26 Bioalliance Pharma Vehicule bioadhesif pour les muqueuses pour delivrer lentement des principes actifs
US20070260491A1 (en) * 2006-05-08 2007-11-08 Pamela Palmer System for delivery and monitoring of administration of controlled substances
US20070286900A1 (en) * 2006-06-09 2007-12-13 Catherine Herry Low dose tablets of opioid analgesics and preparation process
US20080069891A1 (en) * 2006-09-15 2008-03-20 Cima Labs, Inc. Abuse resistant drug formulation
US20070299687A1 (en) * 2006-06-23 2007-12-27 Pamela Palmer Inpatient system for patient-controlled delivery of oral transmucosal medications dosed as needed
DK2054031T3 (en) 2006-07-21 2016-05-17 Biodelivery Sciences Int Inc Transmucosal delivery devices with improved uptake
US8445018B2 (en) 2006-09-15 2013-05-21 Cima Labs Inc. Abuse resistant drug formulation
US20080090874A1 (en) * 2006-09-20 2008-04-17 Messina John C Jr Treatment of breakthrough pain in patients suffering from chronic low back pain
FR2907680B1 (fr) * 2006-10-27 2012-12-28 Scras Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur induite par au moins un agent anti-cancereux
JP5484062B2 (ja) * 2006-12-04 2014-05-07 オレクソ・アクチエボラゲット オピオイドを含む新規の非−乱用性医薬組成物
CA2677281C (fr) 2007-02-09 2019-10-29 Durect Corporation Formes posologiques par voie orale comprenant du sufentanile et de la naloxone
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
US20080287494A1 (en) * 2007-04-24 2008-11-20 Cephalon, Inc. Transmucosal treatment methods in patients with mucositis
US20100184785A1 (en) * 2007-06-06 2010-07-22 Basf Se Pharmaceutical formulation for the production of chewable tablets and lozenges
PT2180844T (pt) 2007-08-02 2018-04-06 Insys Dev Co Inc Nebulizador sub-lingual de fentanilo
US8945592B2 (en) 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
EP2295046B1 (fr) * 2009-09-14 2012-12-19 Acino AG Système thérapeutique transdermique destiné à l'application de fentanyle ou d'une matière analogue
AU2010300641B2 (en) 2009-09-30 2016-03-17 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
TR201902233T4 (tr) 2009-10-30 2019-03-21 Ix Biopharma Ltd Hızlı çözünen katı dozaj formu.
JP2013526523A (ja) 2010-05-11 2013-06-24 シマ ラブス インク． メトプロロールを含むアルコール耐性持続放出性経口剤形
US20120183580A1 (en) * 2011-01-13 2012-07-19 Theralpha Analgesic Composition for Transbuccal Administration
KR101944367B1 (ko) 2011-08-18 2019-01-31 바이오딜리버리 사이언시스 인터내셔널 인코포레이티드 부프레노르핀 운반용 약물남용 억제 점막 부착 장치
PL2915525T3 (pl) 2011-09-19 2022-01-17 Orexo Ab Tabletki podjęzykowe niepodatne na nadużywanie zawierające buprenorfinę i nalokson
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
DE102012006396A1 (de) 2012-03-29 2013-10-02 Willy Rüsch GmbH Tracheostomietubus
PL2849730T3 (pl) 2012-05-02 2017-05-31 Orexo Ab Nowa kompozycja zawierająca alfentanyl do leczenia ostrego bólu
JP5922851B2 (ja) 2012-11-30 2016-05-24 アキュラ・ファーマシューティカルズ・インコーポレーテッド 活性医薬成分の自己制御放出
US20150118300A1 (en) 2013-10-31 2015-04-30 Cima Labs Inc. Immediate Release Abuse-Deterrent Granulated Dosage Forms
MX2015006022A (es) * 2014-02-07 2015-10-14 Scilabs Pharmaceuticals Sistemas de administracion de farmacos sublinguales, totalmente naturales, no toxicos.
US20160144528A1 (en) 2014-11-25 2016-05-26 Biodelivery Sciences International, Inc. Patch devices, methods and apparatus for forming, and testing pharmaceutical agent delivery patch devices
WO2017040607A1 (fr) 2015-08-31 2017-03-09 Acura Pharmaceuticals, Inc. Procédés et compositions pour la libération auto-régulée d'un ingrédient pharmaceutique actif
US20220062200A1 (en) 2019-05-07 2022-03-03 Clexio Biosciences Ltd. Abuse-deterrent dosage forms containing esketamine
EP3965733A4 (fr) 2019-05-07 2023-01-11 Clexio Biosciences Ltd. Formes posologiques dissuasives d'abus contenant de l'eskétamine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8332556D0 (en) * 1983-12-06 1984-01-11 Reckitt & Colmann Prod Ltd Analgesic compositions
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
SE8800080L (sv) * 1988-01-13 1989-07-14 Kabivitrum Ab Laekemedelskomposition
JP3836566B2 (ja) * 1996-05-13 2006-10-25 久光製薬株式会社 フェンタニル含有経皮投与テープ製剤
JP3943724B2 (ja) * 1998-07-31 2007-07-11 東光薬品工業株式会社 フェンタニル含有経皮投与マトリックス型貼付剤
SE9803240D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action

Also Published As

Publication number Publication date
AU764473B2 (en) 2003-08-21
CA2345064A1 (fr) 2000-03-30
ATE247950T1 (de) 2003-09-15
HU230688B1 (hu) 2017-09-28
DE69910803D1 (de) 2003-10-02
KR100760531B1 (ko) 2007-10-04
TR200100812T2 (tr) 2001-07-23
SK4012001A3 (en) 2001-10-08
HU228992B1 (en) 2013-07-29
JP4478512B2 (ja) 2010-06-09
US6759059B1 (en) 2004-07-06
AU6492899A (en) 2000-04-10
NZ510646A (en) 2004-04-30
NO20011502L (no) 2001-03-23
CA2345064C (fr) 2008-05-27
CN1328448A (zh) 2001-12-26
BG105380A (en) 2001-12-29
ES2207295T3 (es) 2004-05-16
JP2002526440A (ja) 2002-08-20
JP2004269545A (ja) 2004-09-30
PL347467A1 (en) 2002-04-08
WO2000016751A1 (fr) 2000-03-30
HUP0103621A3 (en) 2005-05-30
CZ301562B6 (cs) 2010-04-14
RU2232580C2 (ru) 2004-07-20
NO20011502D0 (no) 2001-03-23
IL142126A (en) 2006-04-10
EE200100176A (et) 2002-08-15
SE9803239D0 (sv) 1998-09-24
IL142126A0 (en) 2002-03-10
BG65363B1 (bg) 2008-04-30
BR9913948A (pt) 2001-06-12
HUP0103621A2 (hu) 2002-02-28
KR20010075314A (ko) 2001-08-09
NO332228B1 (no) 2012-07-30
CN1170524C (zh) 2004-10-13
CZ20011030A3 (cs) 2001-09-12
BR9913948B1 (pt) 2011-02-08
EP1115384A1 (fr) 2001-07-18
PL197078B1 (pl) 2008-02-29
DK1115384T3 (da) 2003-12-22
EP1115384B1 (fr) 2003-08-27
PT1115384E (pt) 2004-01-30
DE69910803T2 (de) 2004-06-17

Similar Documents

Publication Publication Date Title
EP1115384B1 (fr) Composition de fentanyl pour le traitement des douleurs aigues
CA2820588C (fr) Composition pharmaceutique pour le traitement des maladies aigues
MXPA01003063A (en) Fentanyl composition for the treatment of acute pain

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20190924